Progesterone receptor A and B protein expression in human breast cancer

Journal of Steroid Biochemistry and Molecular Biology

Volumn 56, Issue 1-6, 1996, Pages 93-98

  Graham, J Dinny ^a   Yeates, Christine ^a   Balleine, Rosemary L ^a   Harvey, Suzanna S ^a,b   Milliken, Jane S ^c   Bilous, A Michael ^c   Clarke, Christine L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Applied Biosystems Ltd   (United Kingdom)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR; RECEPTOR SUBTYPE;

AGE; BREAST CANCER; CONFERENCE PAPER; CYTOCHEMISTRY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PROTEIN VARIANT;

EID: 0001198305     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00226-X     Document Type: Conference Paper

References (33)

1. Clarke C. L. and Sutherland R. L.: Progestin regulation of cellular proliferation. Endocr. Rev. 11 (1990) 266-301.
2. Schrader W. T. and O'Malley B. W.: Progesterone-binding components of chick oviduct. Characterization of purified subunits. J. Biol. Chem. 247 (1972) 51-59.
3. Horwitz K. B. and Alexander P. S.: In situ photolinked nuclear progesterone receptors of human breast cancer cells: subunit molecular weights after transformation and translocation. Endocrinology 113 (1983) 2195-2201.
4. Tsai M.-J. and O'Malley B. W.: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63 (1994) 451-486.
5. Savouret J. F., Misrahi M. and Milgrom E.: Molecular action of progesterone. Int. J. Biochem. 22 (1990) 579-594.
6. Feil P. D., Clarke C. L. and Satyaswaroop P. G.: Progestin mediated changes in progesterone receptor forms in the normal human endometrium. Endocrinology 123 (1988) 2506-2513.
7. Alexander I. E., Clarke C. L., Shine J. and Sutherland R. L.: Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. Molec. Endocr. 3 (1989) 1377-1386.
8. Lessey B. A., Alexander P. S. and Horwitz K. B.: The subunit structure of human breast cancer progesterone receptors: characterization by chromatography and photoaffinity labeling. Endocrinology 112 (1983) 1267-1274.
9. Sheridan P. L., Francis M. D. and Horwitz K. B.: Synthesis of human progesterone receptors in T47D cells. Nascent A- and B-receptors are active without a phosphorylation-dependent post-translational maturation step. J. Biol. Chem. 264 (1989) 7054-7058.
10. Kastner P., Krust A., Turcotte B., Stropp U., Tora L., Gronemeyer H. and Chambon P.: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9 (1990) 1603-1614.
11. Tora L., Gronemeyer H., Turcotte B., Gaub M. P. and Chambon P.: The N-terminal region of the chicken progesterone receptor specifies target gene activation. Nature 333 (1988) 185-188.
12. Meyer M.-E., Quirin-Stricker C., Lerouge T., Bocquel M.-T. and Gronemeyer H.: A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms. J. Biol. Chem. 267 (1992) 10,882-10,887.
13. Tung L., Mohamed M. K., Hoeffler J. P., Takimoto G. S. and Horwitz K. B.: Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Molec. Endocr. 7 (1993) 1256-1265.
14. Vegeto E., Shabaz M. M., Wen D. X., Goldman M. E., O'Malley B. W. and McDonnell D. P.: Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Molec. Endocr. 7 (1993) 1244-1255.
15. McDonnell D. P., Shahbaz M. M., Vegeto E. and Goldman M. E.: The human progesterone receptor A-form functions as a transcriptional modulator of mineralocorticoid receptor transcriptional activity. J. Steroid Biochem. Molec. Biol. 48 (1994) 425-432.
16. McDonnell D. P. and Goldman M. E.: RU486 exerts anti-estrogenic activities through a novel progesterone receptor A form-mediated mechanism. J. Biol. Chem. 269 (1994) 11,945-11,949.
17. Wen D. X., Xu Y.-F., Mais D. E., Goldman M. E. and McDonnell D. P.: The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Molec. Cell. Biol. 14 (1994) 8356-8364.
18. Chalbos D. and Galtier F.: Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription. J. Biol. Chem. 269 (1994) 23,007-23,012.
19. Kraus W. L., Weis K. E. and Katzenellenbogen B. S.: Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Molec. Cell. Biol. 15 (1995) 1847-1857.
20. Loosfelt H., Logeat F., Vu Hai M. T. and Milgrom E.: The rabbit progesterone receptor. Evidence for a single steroid-binding subunit and characterization of receptor mRNA. J. Biol. Chem. 259 (1984) 14,196-14,202.
21. 3H]R5020 photoaffinity labelling: evidence that the A and B subunits are not equimolar. Endocrinology 120 (1987) 1449-1456.
22. Schneider W., Ramachandran C., Satyaswaroop P. G. and Shyamala G.: Murine progesterone receptor exists predominantly as the 83-kilodalton 'A' form. J. Steroid Biochem. Molec. Biol. 38 (1991) 285-291.
23. Boyd P. A. and Spelsberg T. C.: Seasonal changes in the molecular species and nuclear binding of chick oviduct progesterone receptor. Biochem. 18 (1979) 3685-3690.
24. Boyd-Leinen P. A., Fournier D. and Spelsberg T. C.: Nonfunctioning progesterone receptors in the developed oviducts from estrogen-withdrawn immature chicks and in aged nonlaying hens. Endocrinology 111 (1982) 30-36.
25. Horwitz K. B. and McGuire W. L.: Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253 (1978) 2223-2228.
26. Horwitz K. B., Wei L. L., Sedlacek S. M. and d'Arville C. N.: Progestin action and progesterone receptor structure in human breast cancer: a review. Recent Prog. Horm. Res. 41 (1985) 249-316.
27. McGuire W. L., Chamness G. C. and Fuqua S. A. W.: Estrogen receptor variants in clinical breast cancer. Molec. Endocr. 5 (1991) 1571-1577.
28. Clarke C. L., Zaino R. J., Feil P. D., Miller J. V., Steck M. E., Ohlsson-Wilhelm B. M. and Satyaswaroop P. G.: Monoclonal antibodies to human progesterone receptor: characterization by biochemical and immunohistochemical techniques. Endocrinology 121 (1987) 1123-1132.
29. Sheridan P. L., Krett N. L., Gordon J. A. and Horwitz K. B.: Human progesterone receptor transformation and nuclear down-regulation are independent of phosphorylation. Molec. Endocr. 2 (1988) 1329-1342.
30. Wei L. L., Gonzalez-Aller C., Wood W. M., Miller L. A. and Horwitz K. B.: 5′-Heterogeneity in human progesterone receptor transcripts predicts a new amino-terminal truncated "C"-receptor and unique A-receptor messages. Molec. Endocr. 4 (1990) 1833-1840.
31. Fuqua S. A. W., Chamness G. C. and McGuire W. L.: Estrogen receptor mutations in breast cancer. J. Cell. Biochem. 51 (1993) 135-139.
32. Gronemeyer H.: Transcription activation by estrogen and progesterone receptors. Ann. Rev. Genet. 25 (1991) 89-123.
33. Sartorius C. A., Melville M. Y., Hovland A. R., Tung L., Takimoto G. S. and Horwitz K. B.: A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B isoform. Molec. Endocr. 8 (1994) 1347-1360.